Baicalein Sensitizes Radioresistant BT549 and MCF7 ‐R Breast Cancer Cells by Modulating Rac1 Signaling
Phytotherapy Research · 2026-11 · 40 (11) · 6047-6068
DOI: 10.1002/ptr.70376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 02.06.2026. Verfasst von Zitong Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Comprehensive Breast Care Center, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China. Hauptthemen laut MEDLINE: Flavanones, rac1 GTP-Binding Protein, Breast Neoplasms, Radiation Tolerance. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Construction project of Key Laboratory of Tumor Prevention and Treatment of Integrated Traditional Chinese and Western Medicine of Shaanxi Province, National Natural Science Foundation of China, Key Research and Development Program of Shaanxi.
Abstract (Originalsprache)
Radioresistance remains a key barrier in breast cancer (BC) treatment. Baicalein, a flavonoid from Scutellaria baicalensis, has shown potential to enhance radiosensitivity. This study investigates its efficacy and mechanism in radioresistant BC models. Radioresistant BC cell models were established via fractionated irradiation and validated by clonogenic assays. Baicalein's radiosensitizing effects were assessed using clonogenic survival and DNA damage assays (γ‐H2AX foci and neutral comet). KEGG and protein–protein interaction analyses identified Rac1 as a key mediator. Molecular docking and 100 ns molecular dynamics (MD) simulations evaluated the binding stability of the Rac1‐baicalein complex, with binding free energy calculated via gmx_MMPBSA. Rac1 activity, immunoblotting, immunofluorescence, and comet assays demonstrated that baicalein inhibits Rac1 activity and delays DNA repair. In vivo xenograft studies ( n = 5 mice/group) with immunohistochemistry validated Rac1 pathway inhibition. Baicalein enhanced radiosensitivity in BT549 (radiation enhancement ratio, ER = 2.20 ± 0.12) and MCF7‐R cells (ER = 1.38 ± 0.10). Molecular docking revealed a strong binding affinity (−6.87 kcal/mol) between baicalein and Rac1, with MD simulations indicating a relatively stable interaction (binding free energy: −73.42 kJ/mol). Surface plasmon resonance (SPR) analysis revealed a direct interaction between baicalein and Rac1 protein with moderate affinity ( K D = 2.91 × 10 −6 M). High Rac1 expression correlated with poorer clinical outcomes in overall survival (OS), disease specific survival (DSS), and progress free interval (PFI). Baicalein delayed DNA repair after radiation by inhibiting Rac1 activity via the NHEJ pathway, an effect reversed by a constitutively active Rac1‐Q61L plasmid. In vivo, baicalein inhibited Rac1, slowing tumor growth and enhancing radiosensitivity. Baicalein is a potential radiosensitizer, offering a novel strategy to overcome radioresistance in breast cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Comprehensive Breast Care Center, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.
- Department of Gastroenterology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, People's Republic of China.
- Department of Pathology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, the First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, People's Re…
ORCID-Profile: Zitong Zhao, Shuqun Zhang
Förderung
- Construction project of Key Laboratory of Tumor Prevention and Treatment of Integrated Traditional Chinese and Western Medicine of Shaanxi Province
- National Natural Science Foundation of China
- Key Research and Development Program of Shaanxi
- Key Research and Development Projects of Shaanxi Province
Zitieren
APA
Zhao, Z., Li, Z., Peng, Q., & Zhang, S. (2026). Baicalein Sensitizes Radioresistant BT549 and MCF7 ‐R Breast Cancer Cells by Modulating Rac1 Signaling. Phytotherapy Research, 40(11), 6047-6068. https://doi.org/10.1002/ptr.70376
Vancouver
Zhao Z, Li Z, Peng Q, Zhang S. Baicalein Sensitizes Radioresistant BT549 and MCF7 ‐R Breast Cancer Cells by Modulating Rac1 Signaling. Phytotherapy Research. 2026;40(11):6047-6068. doi:10.1002/ptr.70376
BibTeX
@article{Zhao2026,
author = {Zhao, Zitong and Li, Zhangyun and Peng, Quanzhou and Zhang, Shuqun},
title = {Baicalein Sensitizes Radioresistant BT549 and MCF7 ‐R Breast Cancer Cells by Modulating Rac1 Signaling},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {11},
pages = {6047--6068},
doi = {10.1002/ptr.70376}
}
EUVIMED